Jt Stratford LLC Merck & Co., Inc. Transaction History

Jt Stratford LLC

$701 Million
Q3 2025

A detailed history of Jt Stratford LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Jt Stratford LLC holds 13,014 shares of MRK stock, worth $1.21 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

13,014

Previous 17,615 26.12%

Holding current value

$1.21 Million

Previous $1.39 Million 21.66%

% of portfolio

0.16%

Previous 0.22%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$77.6 - $87.37 $357,037 - $401,989	-4,601 Reduced 26.12%	13,014 $1.09 Million
Q2 2025 Aug 13, 2025	SELL	$73.47 - $87.12 $76,629 - $90,866	-1,043 Reduced 5.59%	17,615 $1.39 Million
Q1 2025 May 14, 2025	BUY	$83.01 - $101.02 $1.02 Million - $1.24 Million	12,268 Added 191.99%	18,658 $1.67 Million
Q4 2024 Feb 18, 2025	SELL	$96.31 - $114.76 $4,815 - $5,738	-50 Reduced 0.78%	6,390 $635,000
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $61,910 - $71,836	557 Added 9.47%	6,440 $731,000

Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $19,065 - $20,475	-154 Reduced 2.55%	5,883 $728,000
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $33,745 - $39,321	-298 Reduced 4.7%	6,037 $796,000
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $11,520 - $12,537	115 Added 1.85%	6,335 $690,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $597,418 - $663,456	-5,803 Reduced 48.27%	6,220 $640,000
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $640,907 - $698,560	5,901 Added 96.39%	12,023 $1.39 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $160,380 - $178,951	-1,558 Reduced 20.29%	6,122 $651,000
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $266,254 - $341,374	3,045 Added 65.7%	7,680 $851,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $13,271 - $14,908	-157 Reduced 3.28%	4,635 $399,000
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $14,777 - $16,751	-177 Reduced 3.56%	4,792 $437,000
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $85,345 - $95,666	-1,161 Reduced 18.94%	4,969 $408,000
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $17,564 - $22,001	243 Added 4.13%	6,130 $470,000
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $6,379 - $7,015	-89 Reduced 1.49%	5,887 $442,000
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $1,898 - $2,099	27 Added 0.45%	5,976 $465,000
Q1 2021 May 12, 2021	SELL	$68.86 - $81.11 $35,600 - $41,933	-517 Reduced 8.0%	5,949 $459,000
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $28,923 - $32,098	403 Added 6.65%	6,466 $529,000
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $200,586 - $227,365	-2,741 Reduced 31.13%	6,063 $503,000
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $180,486 - $205,373	2,563 Added 41.07%	8,804 $681,000
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $106,888 - $148,152	-1,687 Reduced 21.28%	6,241 $480,000
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $171,994 - $194,076	-2,217 Reduced 21.85%	7,928 $721,000
Q3 2019 Nov 19, 2019	BUY	$76.08 - $82.93 $127,662 - $139,156	1,678 Added 19.82%	10,145 $854,000
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $1.6 Million - $1.87 Million	-22,910 Reduced 73.02%	8,467 $710,000
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $548,847 - $625,991	-7,888 Reduced 20.09%	31,377 $2.61 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $159,185 - $184,732	-2,440 Reduced 5.85%	39,265 $3 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $34,383 - $40,432	-596 Reduced 1.41%	41,705 $2.96 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $1,169 - $1,373	23 Added 0.05%	42,301 $2.57 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $232,683 - $270,444	4,566 Added 12.11%	42,278 $2.3 Million
Q4 2017 Feb 15, 2018	SELL	$51.62 - $61.64 $223,875 - $267,332	-4,337 Reduced 10.31%	37,712 $2.12 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $2.47 Million - $2.65 Million	42,049	42,049 $2.69 Million

Others Institutions Holding MRK

# of Institutions

3,878

Shares Held

1.9B

Call Options Held

30.1M

Put Options Held

27.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jt Stratford LLC with notifications on news.

Account